Drugs / diphtheria-tetanus vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00004800 | Sep 1992 → ? | pertussis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 3 | NCT00004799 | Apr 1991 → ? | pertussis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | diphtheria-tetanus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004800 ↗ |
| Modality | Vaccine | “The fourth group receives a diphtheria-tetanus vaccine as the control.” NCT00004799 ↗ |
| Route | Intramuscular | “All vaccines are given as an intramuscular injection” NCT00004799 ↗ |